Antibiotice Ia (ATB) — Financial Flexibility Index
Antibiotice Ia (ATB) has a Financial Flexibility Index of 0.11x as of June 2026. Free cash flow of RON67.96 Million (operating CF RON18.71 Million minus capex RON49.25 Million) represents 0% of total liabilities (RON623.78 Million). Explore ATB capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Antibiotice Ia Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Antibiotice Ia across 4 annual periods. Check ATB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for Antibiotice Ia (2022–2025)
Year-by-year free cash flow to debt coverage for Antibiotice Ia. For the full cash flow conversion analysis, see Antibiotice Ia (ATB) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (RON) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | RON215.05 Million | RON72.44 Million | RON460.49 Million | ▼ -14.9% |
| 2024 | 0.55x | RON211.31 Million | RON95.15 Million | RON384.95 Million | ▼ -27.3% |
| 2023 | 0.75x | RON220.50 Million | RON122.46 Million | RON292.21 Million | ▲ +4.3% |
| 2022 | 0.72x | RON155.54 Million | RON115.66 Million | RON215.04 Million | — |